Cel-Sci
CVM
#10574
Rank
NZ$60.8 M
Marketcap
NZ$3.46
Share price
-0.51%
Change (1 day)
-80.08%
Change (1 year)

Cel-Sci (CVM) - Total assets

Total assets on the balance sheet as of June 2026 : NZ$38.05 Million

According to Cel-Sci 's latest financial reports the company's total assets are NZ$38.05 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Cel-Sci - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-09-30NZ$48.57 M14.2%
2024-09-30NZ$42.53 M-16.47%
2023-09-30NZ$50.92 M-43.19%
2022-09-30NZ$89.63 M-18.52%
2021-09-30NZ$0.11 B79.73%
2020-09-30NZ$61.2 M38.76%
2019-09-30NZ$44.11 M-1.25%
2018-09-30NZ$44.66 M40.13%
2017-09-30NZ$31.87 M-7.01%
2016-09-30NZ$34.27 M-23.3%
2015-09-30NZ$44.69 M81.48%
2014-09-30NZ$24.62 M88.48%
2013-09-30NZ$13.06 M-32.68%
2012-09-30NZ$19.4 M-20.02%
2011-09-30NZ$24.26 M-52.9%
2010-09-30NZ$51.52 M-20.12%
2009-09-30NZ$64.49 M195.79%
2008-09-30NZ$21.8 M-19.39%
2007-09-30NZ$27.04 M82.89%
2006-09-30NZ$14.78 M230.36%
2005-09-30NZ$4.47 M-45.45%
2004-09-30NZ$8.2 M66.5%
2003-09-30NZ$4.92 M-38.46%
2002-09-30NZ$8 M-27.72%
2001-09-30NZ$11.08 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
NZ$358.27 B 941,399.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$170.41 B 447,744.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$1.29 B 3,294.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
NZ$33.8 M-11.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$71.02 B 186,536.64%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
NZ$0.99 B 2,512.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$1.99 B 5,129.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ$11.25 M-70.43%๐Ÿ‡บ๐Ÿ‡ธ USA